HYCAMTIN
Active substance: topotecan
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · TOPOTECAN HYDROCHLORIDE 4 mg/4mL
United StatesActive
Marketing holder: Novartis Pharmaceuticals Corporation
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- TOPOTECAN HYDROCHLORIDE · 4 mg/4mL
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 6 |
|
| EU 8 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-ba8b-718c-884d-f3fd9e6e35a9,01a120c4-ce68-7d57-8c7a-a2fdaa467a37,01a120c5-077e-7ae2-bb40-ae38898cd12e,01a120c5-6228-7b1d-a11f-c15ff83b2a1f,01a120c5-a39f-7c9f-8d92-a5faecebf4c4;count=5 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4af3-771d-b015-0e04b3512c94,01a1208c-9c17-72f6-99de-7b63206ebd40,01a1208f-8a68-7a38-91ca-599996f53d59,01a12090-4328-7ee1-9604-15ce155727f1,01a12092-8e74-76d5-bc5c-13590a9f3457;count=8 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 0078-0674
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
- product · openFDA NDC · 0078-0674 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0078-0674 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0078-0674 · Verified 2026-10-09 · open in source